This inventor holds 1 USPTO granted patent. Top assignee: Cephalon, Inc.. Active years: 2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001
Title: The Innovations of Thomas M Engber
Introduction
Thomas M Engber is a notable inventor based in Berwyn, PA (US). He has made significant contributions to the field of therapeutics, particularly through his work on a derivative of the indolocarbazole K-252a. His innovative approach has led to the development of methodologies that hold promise for therapeutic applications.
Latest Patents
Engber holds 1 patent for the use of K-252a derivative. This patent discloses therapeutic methodologies utilizing a ring substituted derivative of K-252a, which is represented by a specific chemical formula. This work showcases his commitment to advancing medical science and improving therapeutic options.
Career Highlights
Engber is associated with Cephalon, Inc., a company known for its focus on developing innovative therapies. His role at Cephalon has allowed him to contribute to groundbreaking research and development in the pharmaceutical industry.
Collaborations
Throughout his career, Engber has collaborated with notable colleagues, including Forrest A Haun and Michael S Saporito. These collaborations have likely enriched his research and expanded the impact of his work in the field.
Conclusion
Thomas M Engber's contributions to the field of therapeutics through his innovative patent and collaborations highlight his role as a significant inventor. His work continues to influence the development of new therapeutic methodologies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile